DNER and acute leukemia: Owing to the exhaustive pharmacological explorations, one of the compound, QCA570 (78) emerged as an extremely potent BET degrader 78 that demonstrated BET proteins degradation along with cell growth inhibitory activity towards human acute leukemia cell lines at low picomolar concentrations.